The U.S. Food and Drug Administration recently announced that the agency will hold two public meetings on AquAdvantage Salmon, a genetically modified (GM) Atlantic salmon intended to be used for food, on September 19-21, 2010.
According to an announcement, the FDA Veterinary Medicine Advisory Committee will address science-based issues